Treatment histories, barriers, and preferences for individuals with symptoms of generalized anxiety disorder

被引:4
|
作者
Basile, Vesna Trenoska [1 ]
Newton-John, Toby [1 ]
Wootton, Bethany M. [1 ,2 ]
机构
[1] Univ Technol Sydney, Grad Sch Hlth, Discipline Clin Psychol, Ultimo, NSW, Australia
[2] Univ Technol Sydney, Grad Sch Hlth, Discipline Clin Psychol, POB 123 Broadway, Ultimo, NSW 2007, Australia
关键词
cognitive behavioral therapy; GAD; generalized anxiety disorder; Health Belief Model; health promotion; mental health services; treatment barriers; treatment histories; treatment preferences; HELP-SEEKING INTENTION; HEALTH BELIEF MODEL; COGNITIVE-BEHAVIOR THERAPY; MENTAL-HEALTH; PANIC DISORDER; NATIONAL-SURVEY; METAANALYSIS; DEPRESSION; VARIABLES; VALIDITY;
D O I
10.1002/jclp.23665
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Generalized anxiety disorder (GAD) is a prevalent and chronic mental health condition, associated with considerable individual and economic burden. Despite the availability of effective treatments, many individuals do not access support. The current study explores treatment histories, barriers to help-seeking, and cognitive behavioral therapy (CBT) treatment preferences for individuals with clinically significant GAD symptoms. The utility of Health Belief Model (HBM) in predicting help-seeking is also examined. A cross-sectional design with 127 participants (Mage = 29.17; SD = 11.86; 80.3% female) was used. Sixty-two percent of participants reported previously seeking psychological treatment, and approximately 28% received CBT in the first instance. The most influential treatment barriers were a desire to solve the problem on one's own (M = 1.96, SD = 0.96), followed by affordability (M = 1.75, SD = 1.15) and feeling embarrassed or ashamed (M = 1.75, SD = 1.06). The most preferred treatment modes were in-person individual treatment (M = 7.59, SD = 2.86) followed by remote treatment via videoconferencing (M = 4.31, SD = 3.55). Approximately 38% of the variance in intention to seek treatment was associated with the HBM variables, with perceived benefit of treatment being the strongest predictor. Results have the potential to inform mental health service delivery by reducing treatment barriers and aligning public health campaigns with benefits of psychological treatments.
引用
收藏
页码:1286 / 1305
页数:20
相关论文
共 50 条
  • [1] Treatment barriers, preferences and histories of individuals with symptoms of body dysmorphic disorder
    McCausland, Jessica
    Paparo, Josephine
    Wootton, Bethany M.
    BEHAVIOURAL AND COGNITIVE PSYCHOTHERAPY, 2021, 49 (05) : 582 - 595
  • [2] A Preliminary Examination of Treatment Barriers, Preferences, and Histories of Women with Symptoms of Social Anxiety Disorder
    Black, Julie. A.
    Paparo, Josephine
    Wootton, Bethany M. M.
    BEHAVIOUR CHANGE, 2023, 40 (04) : 267 - 277
  • [3] Barriers to Mental Health Treatment Among Individuals With Social Anxiety Disorder and Generalized Anxiety Disorder
    Goetter, Elizabeth M.
    Frumkin, Madelyn R.
    Palitz, Sophie A.
    Swee, Michaela B.
    Baker, Amanda W.
    Bui, Eric
    Simon, Naomi M.
    PSYCHOLOGICAL SERVICES, 2020, 17 (01) : 5 - 12
  • [4] Understanding barriers to treatment and treatment delivery preferences for individuals with symptoms of hoarding disorder: A preliminary study
    Robertson, Lea
    Paparo, Josephine
    Wootton, Bethany M.
    JOURNAL OF OBSESSIVE-COMPULSIVE AND RELATED DISORDERS, 2020, 26
  • [5] Psychiatrists' treatment preferences for generalized anxiety disorder
    Latas, Milan
    Trajkovic, Goran
    Bonevski, Dimitar
    Naumovska, Andromahi
    Latas, Dusanka Vucinic
    Bukumiric, Zoran
    Starcevic, Vladan
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2018, 33 (01)
  • [6] Understanding psychological treatment barriers, preferences and histories of individuals with clinically significant depressive symptoms in Australia: a preliminary study
    Smith, Sinead
    Paparo, Josephine
    Wootton, Bethany M.
    CLINICAL PSYCHOLOGIST, 2021, 25 (02) : 223 - 233
  • [7] Impact of depressieve symptoms on the treatment of generalized social anxiety disorder
    Ledley, DR
    Huppert, JD
    Foa, EB
    Davidson, JRT
    Keefe, FJ
    Potts, NLS
    DEPRESSION AND ANXIETY, 2005, 22 (04) : 161 - 167
  • [8] ETIZOLAM IN THE TREATMENT OF GENERALIZED ANXIETY DISORDER ASSOCIATED WITH DEPRESSIVE SYMPTOMS
    PARIANTE, F
    CADDEO, S
    ECARI, U
    CURRENT MEDICAL RESEARCH AND OPINION, 1989, 11 (09) : 543 - 549
  • [9] Pregabalin in the treatment of core depressive symptoms in generalized anxiety disorder
    Khan, A
    Montgomery, SA
    Simon, N
    Farfel, G
    Tobias, K
    Zornberg, GL
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2004, 14 : S319 - S319
  • [10] INTERACTIONS AMONG INTEROCEPTIVE SENSITIVITY AND INSOMNIA SYMPTOMS IN INDIVIDUALS WITH GENERALIZED ANXIETY DISORDER
    Daffre, C.
    Oliver, K., I
    Valli, B.
    Kleckner, I
    Pace-Schott, E. F.
    SLEEP, 2020, 43 : A424 - A425